Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-01 Sale |
2023-02-02 7:04 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,779 | $21.75 | $38,697 | 143,319 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 7:02 pm |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer |
1,588 | $21.75 | $34,542 | 112,783 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 6:58 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
8,196 | $22.25 | $182,361 | 529,650 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 6:53 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
2,031 | $21.87 | $44,419 | 62,805 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:05 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
1,097 | $21.86 | $23,976 | 34,836 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:05 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
2,062 | $21.5 | $44,333 | 42,376 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:05 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
2,062 | $21.5 | $44,333 | 39,776 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:05 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
6,442 | $21.5 | $138,503 | 147,846 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:05 pm |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer |
852 | $21.9 | $18,663 | 32,871 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:05 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,550 | $21.9 | $33,952 | 63,598 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-06 4:05 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
5,625 | $20.75 | $116,719 | 154,288 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-06 4:05 pm |
Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer |
2,493 | $20.75 | $51,730 | 17,507 (Direct) |
View |
| 2022-10-04 Sale |
2022-10-06 8:10 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
3,042 | $25.68 | $78,119 | 65,148 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 4:05 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
349 | $28 | $9,772 | 35,933 (Direct) |
View |
| 2022-05-11 Sale |
2022-05-12 8:49 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
1,563 | $21.71 | $33,940 | 43,672 (Direct) |
View |
| 2022-05-10 Sale |
2022-05-12 8:47 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
1,950 | $21.51 | $41,943 | 41,838 (Direct) |
View |
| 2022-05-10 Sale |
2022-05-12 8:45 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
2,200 | $21.51 | $47,322 | 35,655 (Direct) |
View |
| 2022-05-10 Sale |
2022-05-12 8:44 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
881 | $21.72 | $19,134 | 35,733 (Direct) |
View |
| 2022-05-11 Sale |
2022-05-12 8:35 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
2,575 | $21.92 | $56,457 | 146,919 (Direct) |
View |
| 2022-02-10 Sale |
2022-02-11 4:05 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
4,832 | $27.84 | $134,523 | 159,913 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:22 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
798 | $26.51 | $21,152 | 54,114 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:20 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
1,350 | $27.4 | $36,990 | 100,988 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:19 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
1,125 | $27.4 | $30,825 | 102,435 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:18 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,125 | $27.4 | $30,825 | 124,497 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:17 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
1,238 | $27.4 | $33,921 | 95,055 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:16 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
4,813 | $27.4 | $131,876 | 372,145 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:38 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
934 | $24.58 | $22,955 | 28,662 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-31 Option Award |
2023-02-02 7:04 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
81,500 | $0 | 143,319 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 7:02 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer |
81,500 | $0 | 112,783 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 7:00 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer |
81,500 | $0 | 99,007 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:58 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
390,000 | $0 | 529,650 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:53 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
30,000 | $0 | 62,805 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-01 6:20 pm |
N/A 2032-08-31 |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer |
62,840 | $0 | 91,563 (Direct) |
View |
Ownership |
2022-09-01 6:19 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer |
0 | $0 | 197,473 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:42 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Williams Brinkley Ruth Director |
12,000 | $0 | 17,250 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:40 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Squarer Ron Director |
12,000 | $0 | 26,875 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:33 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Poole Sandra Director |
12,000 | $0 | 21,500 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:30 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Orwin John A Director |
12,000 | $0 | 26,875 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:26 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
12,000 | $0 | 79,000 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:24 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
12,000 | $0 | 49,000 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:22 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | COUGHLIN TIMOTHY Director |
12,000 | $0 | 47,000 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:20 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director |
12,000 | $0 | 20,250 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:18 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
12,000 | $0 | 29,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:22 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
26,250 | $0 | 54,114 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:20 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer |
8,000 | $0 | 8,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:20 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
67,040 | $0 | 100,988 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:19 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
67,040 | $0 | 102,435 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:18 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
67,040 | $0 | 124,497 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:17 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
67,040 | $0 | 95,055 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:16 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
245,248 | $0 | 372,145 (Direct) |
View |